Sorry, you need to enable JavaScript to visit this website.
Annual Report 2020

Top Management

Executive Committee(as of October 2020)

The Executive Committee discusses important matters of management across Astellas. It is chaired by the Representative Director, President and CEO. Extended members include the officers responsible for research, development and pharmaceutical technology capabilities together with the officers responsible for each commercial region, and these members participate in any necessary discussions at the request of the chairman.

Standing Members

Representative Director, 
President and Chief Executive Officer (CEO)
Kenji Yasukawa, Ph.D.
Representative Director, 
Corporate Executive Vice President, 
Chief Strategy Officer (CStO) and 
Chief Financial Officer (CFO)
Naoki Okamura
Chief Administrative Officer (CAO) and 
Chief Ethics & Compliance Officer (CECO)
Fumiaki Sakurai
Chief Medical Officer (CMO)Bernhardt Zeiher, M.D.
Chief Commercial Officer (CCO)Yukio Matsui
General Counsel (GC)Catherine Levitt

 

Extended Members

President, Drug Discovery ResearchAkihiko Iwai
President, Pharmaceutical TechnologyHideki Shima
President, DevelopmentSteven Benner
President, Established Markets CommercialDirk Kosche
President, Greater China CommercialHiroshi Hamaguchi
President, International Markets CommercialClaus Zieler
President, Japan CommercialYasuhiro Tsutsui
President, US CommercialPercival Barretto-Ko

 

Group Management Structure (As of October 1, 2020)

Group Management Structure